183 related articles for article (PubMed ID: 11531252)
1. Non-melanoma skin cancers and glucocorticoid therapy.
Karagas MR; Cushing GL; Greenberg ER; Mott LA; Spencer SK; Nierenberg DW
Br J Cancer; 2001 Sep; 85(5):683-6. PubMed ID: 11531252
[TBL] [Abstract][Full Text] [Related]
2. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
3. Use of antihypertensive drugs and risk of skin cancer.
Schmidt SA; Schmidt M; Mehnert F; Lemeshow S; Sørensen HT
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1545-54. PubMed ID: 25640031
[TBL] [Abstract][Full Text] [Related]
4. Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.
Baibergenova AT; Weinstock MA;
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1109-15. PubMed ID: 21923839
[TBL] [Abstract][Full Text] [Related]
5. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study.
Jensen AØ; Thomsen HF; Engebjerg MC; Olesen AB; Friis S; Karagas MR; Sørensen HT
Br J Cancer; 2009 Jan; 100(1):200-5. PubMed ID: 19034275
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
7. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin.
Gallagher RP; Bajdik CD; Fincham S; Hill GB; Keefe AR; Coldman A; McLean DI
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):419-24. PubMed ID: 8781736
[TBL] [Abstract][Full Text] [Related]
8. Occupation and keratinocyte cancer risk: a population-based case-control study.
Marehbian J; Colt JS; Baris D; Stewart P; Stukel TA; Spencer SK; Karagas MR
Cancer Causes Control; 2007 Oct; 18(8):895-908. PubMed ID: 17638107
[TBL] [Abstract][Full Text] [Related]
9. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid therapy and risk of bladder cancer.
Dietrich K; Schned A; Fortuny J; Heaney J; Marsit C; Kelsey KT; Karagas MR
Br J Cancer; 2009 Oct; 101(8):1316-20. PubMed ID: 19773763
[TBL] [Abstract][Full Text] [Related]
11. Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study.
Sørensen HT; Mellemkjaer L; Nielsen GL; Baron JA; Olsen JH; Karagas MR
J Natl Cancer Inst; 2004 May; 96(9):709-11. PubMed ID: 15126608
[TBL] [Abstract][Full Text] [Related]
12. Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
Garritsen FM; van der Schaft J; van den Reek JM; Politiek K; van Os-Medendorp H; van Dijk M; Hijnen DJ; de Graaf M; Bruijnzeel-Koomen CA; de Jong EM; Schuttelaar MA; Bruin-Weller MS
Acta Derm Venereol; 2017 Jun; 97(6):724-730. PubMed ID: 28218345
[TBL] [Abstract][Full Text] [Related]
13. Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2014 Mar; 21(3):454-8. PubMed ID: 24330255
[TBL] [Abstract][Full Text] [Related]
14. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire.
Applebaum KM; Karagas MR; Hunter DJ; Catalano PJ; Byler SH; Morris S; Nelson HH
Environ Health Perspect; 2007 Aug; 115(8):1231-6. PubMed ID: 17687452
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
18. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.
Karagas MR; Stukel TA; Morris JS; Tosteson TD; Weiss JE; Spencer SK; Greenberg ER
Am J Epidemiol; 2001 Mar; 153(6):559-65. PubMed ID: 11257063
[TBL] [Abstract][Full Text] [Related]
20. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
